Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS07 - Symposium by Daiichi Sankyo: Targeting Her Pathways In Advanced NSCLC: Emerging Concepts And Future Opportunities (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/08/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
IS08 - Symposium by Pfizer: EGFR+ and ALK+ NSCLC: More Options, Right Choices (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/08/2019
- Location: Vienna (2016)
- Type: Industry Symposia & Workshops
- Track:
-
+
PL01 - New Questions with Imaginative Answers
- 08:15 - 09:45
- 9/08/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track: Advanced NSCLC
- Moderators:Enriqueta Felip, Giorgio Vittorio Scagliotti
-
+
PL01.01 - Tumor-Agnostic Biologically Driven Treatments: An Endless Dream?
08:15 - 08:30 | Presenter: Robert C. Doebele
- Abstract
Loading... -
+
PL01.02 - The Evolution of Tissue Testing for Immunotherapy - Where Next?
08:30 - 08:45 | Presenter: Keith Kerr
- Abstract
Loading... -
+
PL01.03 - Will the Immunotherapy with Newer Biomarkers, Combination Therapy or New Technology Eventually Cure Lung Cancer?
08:45 - 09:00 | Presenter: Tetsuya Mitsudomi
- Abstract
Loading... -
+
PL01.04 - Artificial Intelligence, Big Data and Lung Cancer: Ready to Implement?
09:00 - 09:15 | Presenter: Hugo Aerts
- Abstract
Loading...
-
+
PR02 - Press Conference
- 09:45 - 10:30
- 9/08/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track: Immuno-oncology
-
+
PR02.01 - Summary of Day's Plenary
09:45 - 09:50 | Presenter: Enriqueta Felip
- Abstract
No abstract available for this presentation
-
+
PR02.02 - Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRAS G12C Inhibitor, Evaluated in NSCLC
09:50 - 09:57 | Presenter: Ramaswamy Govindan
- Abstract
No abstract available for this presentation
-
+
PR02.03 - Announcement of JTO Clinical and Research Reports
09:57 - 10:02 | Presenter: Alex A Adjei
- Abstract
No abstract available for this presentation
-
+
PR02.04 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial
10:02 - 10:09 | Presenter: Naiyer A Rizvi
- Abstract
No abstract available for this presentation
-
+
PR02.05 - CheckMate 817: First-Line Nivolumab + Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC
10:09 - 10:16 | Presenter: Fabrice Barlesi
- Abstract
No abstract available for this presentation
-
+
PR02.06 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC
10:16 - 10:23 | Presenter: Corey Jay Langer
- Abstract
No abstract available for this presentation
-
+
PR02.07 - Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC
10:23 - 10:30 | Presenter: Marina Chiara Garassino
- Abstract
No abstract available for this presentation
-
+
ES01 - What Is the Role of Chemotherapy in the Era of Immunotherapy in Advanced NSCLC?
- 10:30 - 12:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Oscar Gerardo Arrieta, Reyes Bernabe
-
+
ES01.01 - Chemotherapy is Strictly Additive to Immunotherapy
10:30 - 10:45 | Presenter: Johan Vansteenkiste | Author(s): Els Wauters
- Abstract
Loading... -
+
ES01.02 - Chemotherapy Enhances the Efficacy of Immunotherapy
10:45 - 11:00 | Presenter: Natasha B Leighl
- Abstract
Loading... -
+
ES01.03 - Chemotherapy Directly Targets the Immune System to Improve Efficacy
11:00 - 11:15 | Presenter: Daniel SW Tan
- Abstract
Loading... -
+
ES01.04 - Immunotherapy, Radiotherapy and Chemotherapy Combination: A Potential New Standard?
11:15 - 11:30 | Presenter: Maurice Perol
- Abstract
Loading... -
+
ES01.05 - Future of Dual Anti-CTLA4 and PD1/PDL1 Blockade
11:30 - 11:45 | Presenter: David R Spigel
- Abstract
No abstract available for this presentation
-
+
ES01.06 - Q&A
11:45 - 12:00
- Abstract
No abstract available for this presentation
-
+
ES02 - Management of Oncogene Addicted Patients with Stage III NSCLC
- 10:30 - 12:00
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Carlos Camps, Helena A Yu
-
+
ES02.01 - Biomarker Testing in LA Disease
10:30 - 10:45 | Presenter: Helena A Yu
- Abstract
Loading... -
+
ES02.02 - Management of EGFR LA Disease
10:45 - 11:00 | Presenter: Keunchil Park
- Abstract
Loading... -
+
ES02.03 - Management of Other Non EGFR Oncogene Addicted Tumors
11:00 - 11:15 | Presenter: Charu Aggarwal
- Abstract
Loading... -
+
ES02.04 - Concurrent, Sequential and Combination Immunotherapy Regimens in LA-NSCLC
11:15 - 11:30 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES02.05 - Q&A
11:30 - 12:00
- Abstract
No abstract available for this presentation
-
+
ES03 - BAP-1 and Other Novel Molecular and Metabolic Targets in Mesothelioma
- 10:30 - 12:00
- 9/08/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Educational Session
- Track: Mesothelioma
- Moderators:Michele Carbone, Miyako Satouchi
-
+
ES03.01 - Targeting Altered microRNA Expression in Mesothelioma
10:30 - 10:40 | Presenter: Glen Reid
- Abstract
Loading... -
+
ES03.02 - Targeting CDKN2A in Mesothelioma
10:40 - 10:50 | Presenter: Dean Anthony Fennell
- Abstract
Loading... -
+
ES03.03 - Targeting NF2 in Mesothelioma
10:50 - 11:00 | Presenter: Yoshitaka Sekido
- Abstract
Loading... -
+
ES03.04 - Pegargiminase to Treat Mesothelioma
11:00 - 11:10 | Presenter: Peter Szlosarek
- Abstract
Loading... -
+
ES03.05 - Inherited Predisposition to Mesothelioma, Biological and Clinical Differences with Sporadic Mesothelioma
11:10 - 11:20 | Presenter: Jane E. Churpek
- Abstract
Loading... -
+
ES03.06 - Q&A
11:20 - 12:00
- Abstract
No abstract available for this presentation
-
+
ES04 - Multimodality Management of Small Cell and Neuroendocrine Cancers
- 10:30 - 12:00
- 9/08/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Educational Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Enric Carcereny, Ben Slotman
-
+
ES04.01 - Update in Systemic Treatment of SCLC
10:30 - 10:40 | Presenter: Sumitra Thongprasert
- Abstract
Loading... -
+
ES04.02 - Pathology Overview for Carcinoid and NE Spectrum
10:40 - 10:50 | Presenter: Elisabeth Brambilla
- Abstract
Loading... -
+
ES04.03 - Surgery for Early and Locally Advanced Small Cell Lung Cancer
10:50 - 11:00 | Presenter: Eric Lim
- Abstract
No abstract available for this presentation
-
+
ES04.04 - Role of Stereotactic Body Radiation in Early and Advanced SCLC
11:00 - 11:10 | Presenter: Roy Decker
- Abstract
Loading... -
+
ES04.05 - Advances in Radionuclide Treatment for Neuroendocrine Tumours
11:10 - 11:20 | Presenter: Angela Lamarca
- Abstract
Loading... -
+
ES04.06 - Systemic Treatment of Large Cell Neuroendocrine Cancer
11:20 - 11:30 | Presenter: Fiona Blackhall
- Abstract
Loading... -
+
ES04.07 - Q&A
11:30 - 12:00
- Abstract
No abstract available for this presentation
-
+
ES05 - Joint Session GLCC/IASLC: Hot Topics for Lung Cancer Advocates
- 10:30 - 12:00
- 9/08/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advocacy
- Moderators:Anne-Marie Baird, Matthew Peters
-
+
Introduction/Poll
10:30 - 10:30
- Abstract
No abstract available for this presentation
-
+
ES05.01 - Lung Cancer Survival: Progress and Challenges
10:30 - 10:45 | Presenter: Marianne Coutts Nicolson
- Abstract
Loading... -
+
ES05.02 - From Living Longer to Also Living Better – the Role of Communication and Interprofessional Collaboration in Metastatic Lung Cancer
10:45 - 11:00 | Presenter: Matthias Villalobos
- Abstract
Loading... -
+
ES05.03 - From Living Longer to Also Living Better; Managing Lung Cancer as a Chronic Disease - the Principle of Survivorship
11:00 - 11:15 | Presenter: Maureen Rigney
- Abstract
Loading... -
+
ES05.04 - Social Media and Lung Cancer - a Global Picture
11:15 - 11:30 | Presenter: Christina Sit | Author(s): Jesme Fox, Simon Malia
- Abstract
Loading... -
+
ES05.05 - Still Struggling for Traction - from Proving Lung Cancer Screening Works to Global Practical Implementation, Including Engagement of the Target Population
11:30 - 11:45 | Presenter: James L Mulshine
- Abstract
Loading... -
+
ES05.06 - Q&A/Poll
11:45 - 12:00
- Abstract
No abstract available for this presentation
-
+
MA01 - Oligometastatic Disease
- 10:30 - 12:00
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Oligometastatic NSCLC
- Moderators:Anne Marie Clasina Dingemans, Matthias Guckenberger
-
+
MA01.01 - Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases
10:30 - 10:35 | Presenter: Shankar Siva | Author(s): Mathias Bressel, Sherene Loi, Shahneen Sandhu, Ben Tran, Jennifer Mooi, Jeremy Lewin, A Azad, D Colyer, Mark Shaw, Sarat Chander, Katherine Cuff, Simon Wood, Nathan Lawrentschuk, Declan Murphy, David Pryor
- Abstract
Loading... -
+
MA01.02 - Lung Stereotactic Body Radiotherapy and Concurrent Immunotherapy: A Multi-Center Safety and Toxicity Analysis
10:35 - 10:40 | Presenter: Sibo Tian | Author(s): Jeffrey M Switchenko, Pretesh R Patel, Joseph W Shelton, Shannon E Kahn, Rathi N Pillai, Conor E Steuer, Taofeek Owonikoko, Madhusmita Behera, Walter J Curran, Kristin A Higgins
- Abstract
Loading... -
+
MA01.03 - Interim Safety Analysis of the Phase IB Trial of SBRT to All Sites of Oligometastatic NSCLC Combined with Durvalumab and Tremelimumab
10:40 - 10:45 | Presenter: Ticiana A. Leal | Author(s): Joshua M Lang, Zachary Morris, Jens Eickhoff, Anne M Traynor, Toby Campbell, Andrew Baschnagel, Michael Bassetti
- Abstract
Loading... -
+
MA01.04 - Discussant - MA01.01, MA01.02, MA01.03
10:45 - 11:00 | Presenter: Fiona McDonald
- Abstract
No abstract available for this presentation
-
+
MA01.05 - Progress of Accompanying GGN Beyond Pulmonary Resection for Non-Small Cell Lung Cancer
11:00 - 11:05 | Presenter: Kanghoon Lee | Author(s): Hyeong Ryul Kim, Seung-Il Park, Dong Kwan Kim, Yong-Hee Kim, Sehoon Choi, Geun Dong Lee, Yong Ho Jeong, Jae Kwang Yun, Yooyoung Chong
- Abstract
Loading... -
+
MA01.06 - Prognostic Factors of Oligometastatic Non-Small Cell Lung Cancer Following Radical Therapy: A Multicenter-Analysis
11:05 - 11:10 | Presenter: Isabelle Opitz | Author(s): miriam Patella, Loic Payrard, Jean Yannis Perentes, Thorsten Krueger, Rolf Inderbitzi, Hans Gelpke, Sandra Schulte, Maja Diezi, MIchel Gonzalez, Walter Weder
- Abstract
Loading... -
+
MA01.07 - Prognostic Factors of Surgical Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients in Oligometastatic Stage-M1b of Disease
11:10 - 11:15 | Presenter: Dariusz Adam Dziedzic | Author(s): Grabczan Wojciech, Rudzinski Piotr, Renata Langfort, Tadeusz Orlowski
- Abstract
Loading... -
+
MA01.08 - Discussant - MA01.05, MA01.06, MA01.07
11:15 - 11:30 | Presenter: Corey Jay Langer
- Abstract
No abstract available for this presentation
-
+
MA01.09 - Concomitant SBRT and EGFR-TKI Versus EGFR-TKI Alone for Oligometastatic NSCLC: A Multicenter, Randomized Phase II Study
11:30 - 11:35 | Presenter: Li Zhang | Author(s): Ping Peng, Yongshun Chen, Guang Han, Rui Meng, Sheng Zhang, Zhengkai Liao, Yujie Zhang, Juejun Gong, Chuangying Xiao, Xiyou Liu, Peng Zhang, Lu Zhang, Shu Xia, Qian Chu, Yuan Chen
- Abstract
Loading... -
+
MA01.10 - Additional Local Consolidative Therapy Showed Survival Benefit Than EGFR-TKIs Alone in Bone Oligometastatic Lung Adenocarcinoma Patients
11:35 - 11:40 | Presenter: Fang Hu | Author(s): Changhui Li, Jianlin Xu, Jindong Guo, Yinchen Shen, Wei Nie, Xiaoxuan Zheng, Lixin Wang, Hai Zhang, Baohui Han, Xueyan Zhang
- Abstract
Loading... -
+
MA01.11 - Improving Survival in Lung Cancer Patients with Oligometastatic Disease Progression Using Stereotactic Body Radiation Therapy
11:40 - 11:45 | Presenter: Luis Raez | Author(s): Miguel Castillo, Ana Botero, Aaron Falchook, Ignacio Castellon, Brian Hunis
- Abstract
Loading... -
+
MA01.12 - Discussant - MA01.09, MA01.10, MA01.11
11:45 - 12:00 | Presenter: Tomoyuki Hishida
- Abstract
No abstract available for this presentation